Vienna, Austria

Azra Pljevljakovic

USPTO Granted Patents = 17 

 

Average Co-Inventor Count = 7.3

ph-index = 4

Forward Citations = 61(Granted Patents)


Company Filing History:


Years Active: 2013-2024

Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents

Title: Azra Pljevljakovic: Innovator in Plasma-Derived Protein Compositions

Introduction: Azra Pljevljakovic is an accomplished inventor based in Vienna, Austria, with an impressive portfolio of 17 patents. Her innovative contributions to the field of biomedicine have made a significant impact, particularly in the development of methods related to plasma-derived protein compositions.

Latest Patents: Among her latest patents is a groundbreaking invention focused on the removal of serine proteases. This method provides novel approaches for reducing the content of serine proteases and/or serine protease zymogens in plasma-derived protein compositions. The invention describes not only the methods for manufacturing these compositions but also aqueous and lyophilized solutions with reduced serine protease content. Additionally, she has developed a new method for producing a highly concentrated immunoglobulin preparation suitable for subcutaneous use. This preparation comprises 20% or more immunoglobulin, enhancing its effectiveness for therapeutic applications.

Career Highlights: Azra has had a successful career, working with notable companies such as Baxalta GmbH and Baxter International Inc. Her expertise has earned her recognition within the industry, and her patented inventions contribute to advancements in healthcare.

Collaborations: Throughout her career, Azra has collaborated with esteemed colleagues like Wolfgang Teschner and Hans-Peter Schwarz. These partnerships have fostered innovative research and development in her field, furthering the potential applications of her patents.

Conclusion: Azra Pljevljakovic exemplifies the spirit of innovation. Her 17 patents highlight her commitment to improving plasma-derived protein compositions and therapeutic methods. Through her groundbreaking work, she continues to push the boundaries of biomedicine, paving the way for better treatment options for patients globally.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…